Was detected in muscle fibers, where it was expressed mainly in

August 22, 2017

Was detected in muscle fibers, where it was expressed mainly in the vicinity of BTX-labeled NMJs, with only 26.3 of the BTX signal co-localizing with BMP4-immunoreactivity (Fig. 2D ). However, in the denervated soleus muscle (Fig. 2D, H ), disappearance of BMP4 immunoreactivity following denervation indicates that expression of BMP4 in muscle cells may be regulated by a motor neuron-derived factor. Agrin is a well known clustering agent for AchR. It is synthesized by motor neurons, anterogradely transported, and released at the nerve terminals [2,21]. We examined whether agrin can also affect BMP4 expression (Fig. 3A and B) or its localization (Fig. 3C ) at the NMJ. Addition of agrin to the medium of differentiated C2C12 muscle cells caused AChR to aggregate on the surface of the myotube (Fig. 3D and E). Agrin caused a dosedependent increase in mRNA expression (Fig. 3A) and in immunoreactivity for BMP4 (Fig. 3B, C and F) in differentiated C2C12 muscle cells, observations that were not seen when agrin was absent from the culture medium (Fig. 3F ). This increase appeared to be BMP4-specific, since BMP2 and BMP6 mRNA expression in differentiated C2C12 muscle cells was not affected by agrin (data not shown). Additionally, localization of BMP4 protein in differentiated C2C12 muscle cells was not affected by agrin, suggesting that targeting of BMP4 to the NMJ may be regulated by other factors that require further investigation (Fig. 3C ).BMP4 is produced by Schwann cells and transported in the motor neuronsLocalization of BMP4 protein in sciatic and hypoglossal nerves was examined by UKI-1 chemical information immunohistochemistry. Intense BMP4-immunoreactivity was detected along longitudinal sections of the sciatic nerve (Fig. 4A) and the hypoglossal nerve (not illustrated). Cross sections of the nerves further confirmed that BMP4 immunoreactivity was associated with the semi-concentric-like structure ofFigure 1. BMPRII proteins are detected at NMJs. (A and B) Adjacent sections of EDL muscle were stained with an anti-BMPRII antibody (A) and a control IgG (B) antibody. The sections were visualized using a color reaction product (AEC). (C ) A single section of EDL muscle was stained with an anti-BMPRII antibody (E; green) and BTX (D; red) to label NMJs. Bright field image (C), BTX in red (D) and BMPRII in green (E) channels were merged using Adobe Photoshop software (F). The Pentagastrin site arrows identify BMPRII immunoreactivity. Arrowheads point to the NMJs labeled by BTX. “m” indicates muscle fibers. Scale bars = 100 mm (A, B) and 50 mm (C ). (G) The overlapping area for BMPRII immunoreactivity and BTX signal was quantified using Image J software. Values are mean 6 SEM (n = 21). doi:10.1371/journal.pone.0058441.gBMP4 and Motor NeuronFigure 2. BMP4 is expressed by muscles. (A) Real-time PCR measurements of BMP2, BMP4 and BMP6 mRNA expression in differentiated C2C12 muscle cells. (B) Real-time PCR measurements of BMP4 mRNA expression in differentiated C2C12 muscle cells and NG108-15 neurons. (C) Real-time PCR measurements of BMPRII and BMP4 mRNA expression in laser capture-isolated lumbar spinal motor neurons. BMPRII mRNA measurement is shown as a positive control here. Data are presented using GAPDH expression level as 100 . Values are mean 6 SEM (n = 6 for A, n = 11 for B and n = 8 for C). (E ) Localization of BMP4 protein (green) in normal (E ) and denernvated (H ) soleus muscles was examined by immunohistochemistry. NMJs were labeled by BTX (red). Grouped panels E, F, G and H,.Was detected in muscle fibers, where it was expressed mainly in the vicinity of BTX-labeled NMJs, with only 26.3 of the BTX signal co-localizing with BMP4-immunoreactivity (Fig. 2D ). However, in the denervated soleus muscle (Fig. 2D, H ), disappearance of BMP4 immunoreactivity following denervation indicates that expression of BMP4 in muscle cells may be regulated by a motor neuron-derived factor. Agrin is a well known clustering agent for AchR. It is synthesized by motor neurons, anterogradely transported, and released at the nerve terminals [2,21]. We examined whether agrin can also affect BMP4 expression (Fig. 3A and B) or its localization (Fig. 3C ) at the NMJ. Addition of agrin to the medium of differentiated C2C12 muscle cells caused AChR to aggregate on the surface of the myotube (Fig. 3D and E). Agrin caused a dosedependent increase in mRNA expression (Fig. 3A) and in immunoreactivity for BMP4 (Fig. 3B, C and F) in differentiated C2C12 muscle cells, observations that were not seen when agrin was absent from the culture medium (Fig. 3F ). This increase appeared to be BMP4-specific, since BMP2 and BMP6 mRNA expression in differentiated C2C12 muscle cells was not affected by agrin (data not shown). Additionally, localization of BMP4 protein in differentiated C2C12 muscle cells was not affected by agrin, suggesting that targeting of BMP4 to the NMJ may be regulated by other factors that require further investigation (Fig. 3C ).BMP4 is produced by Schwann cells and transported in the motor neuronsLocalization of BMP4 protein in sciatic and hypoglossal nerves was examined by immunohistochemistry. Intense BMP4-immunoreactivity was detected along longitudinal sections of the sciatic nerve (Fig. 4A) and the hypoglossal nerve (not illustrated). Cross sections of the nerves further confirmed that BMP4 immunoreactivity was associated with the semi-concentric-like structure ofFigure 1. BMPRII proteins are detected at NMJs. (A and B) Adjacent sections of EDL muscle were stained with an anti-BMPRII antibody (A) and a control IgG (B) antibody. The sections were visualized using a color reaction product (AEC). (C ) A single section of EDL muscle was stained with an anti-BMPRII antibody (E; green) and BTX (D; red) to label NMJs. Bright field image (C), BTX in red (D) and BMPRII in green (E) channels were merged using Adobe Photoshop software (F). The arrows identify BMPRII immunoreactivity. Arrowheads point to the NMJs labeled by BTX. “m” indicates muscle fibers. Scale bars = 100 mm (A, B) and 50 mm (C ). (G) The overlapping area for BMPRII immunoreactivity and BTX signal was quantified using Image J software. Values are mean 6 SEM (n = 21). doi:10.1371/journal.pone.0058441.gBMP4 and Motor NeuronFigure 2. BMP4 is expressed by muscles. (A) Real-time PCR measurements of BMP2, BMP4 and BMP6 mRNA expression in differentiated C2C12 muscle cells. (B) Real-time PCR measurements of BMP4 mRNA expression in differentiated C2C12 muscle cells and NG108-15 neurons. (C) Real-time PCR measurements of BMPRII and BMP4 mRNA expression in laser capture-isolated lumbar spinal motor neurons. BMPRII mRNA measurement is shown as a positive control here. Data are presented using GAPDH expression level as 100 . Values are mean 6 SEM (n = 6 for A, n = 11 for B and n = 8 for C). (E ) Localization of BMP4 protein (green) in normal (E ) and denernvated (H ) soleus muscles was examined by immunohistochemistry. NMJs were labeled by BTX (red). Grouped panels E, F, G and H,.